Agenus (AGEN) Payables (2010 - 2026)
Agenus' (AGEN) quarterly Payables came in at $71.1 million in Q1 2026, up 10.65% year-on-year from $64.2 million in Q1 2025, and down 14.34% quarter-over-quarter from $83.0 million in Q4 2025.
Agenus (AGEN) Payables (2010 - 2026) Analysis & Trends
Agenus' Payables history runs 17 years deep, the most recent figure standing at $71.1 million for Q1 2026.
- On a quarterly basis, Payables rose 10.65% year-over-year to $71.1 million in Q1 2026; TTM through Mar 2026 was $71.1 million, a 10.65% increase from a year earlier, with the FY2025 full-year figure at $83.0 million, up 35.0% from the prior year.
- Payables eased to $71.1 million in Q1 2026 per AGEN's latest filing, from $83.0 million in the prior quarter.
- Across five years, Payables topped out at $85.3 million in Q3 2025 and bottomed at $34.5 million in Q1 2022.
- The 5-year median for Payables is $50.8 million (2024), against an average of $55.6 million.
- Across the five-year window, Payables jumped 113.95% in 2022 and slipped 3.11% in 2024, its largest moves.
- Year by year, Payables stood at $40.9 million in 2022, then soared by 50.09% to $61.4 million in 2023, then climbed by 0.04% to $61.5 million in 2024, then jumped by 35.0% to $83.0 million in 2025, then slipped by 14.34% to $71.1 million in 2026.
- Per Business Quant, the three latest AGEN Payables figures stand at $71.1 million (Q1 2026), $83.0 million (Q4 2025), and $85.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 71.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.08 Mn |
| Dec 31, 2025 | 82.99 Mn |
| Sep 30, 2025 | 85.29 Mn |
| Jun 30, 2025 | 74.40 Mn |
| Mar 31, 2025 | 64.24 Mn |
| Dec 31, 2024 | 61.47 Mn |
| Sep 30, 2024 | 45.90 Mn |
| Jun 30, 2024 | 50.84 Mn |
| Mar 31, 2024 | 50.69 Mn |
| Dec 31, 2023 | 61.45 Mn |
| Sep 30, 2023 | 40.87 Mn |
| Jun 30, 2023 | 52.47 Mn |
| Mar 31, 2023 | 46.77 Mn |
| Dec 31, 2022 | 40.94 Mn |
| Sep 30, 2022 | 39.71 Mn |
| Jun 30, 2022 | 41.00 Mn |
| Mar 31, 2022 | 34.54 Mn |
| Dec 31, 2021 | 30.49 Mn |
| Sep 30, 2021 | 25.12 Mn |
| Jun 30, 2021 | 19.16 Mn |